These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 17018642)
1. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Negishi H; Fujita Y; Yanai H; Sakaguchi S; Ouyang X; Shinohara M; Takayanagi H; Ohba Y; Taniguchi T; Honda K Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15136-41. PubMed ID: 17018642 [TBL] [Abstract][Full Text] [Related]
2. Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. Molle C; Goldman M; Goriely S J Immunol; 2010 Feb; 184(4):1784-92. PubMed ID: 20083668 [TBL] [Abstract][Full Text] [Related]
3. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Takaoka A; Yanai H; Kondo S; Duncan G; Negishi H; Mizutani T; Kano S; Honda K; Ohba Y; Mak TW; Taniguchi T Nature; 2005 Mar; 434(7030):243-9. PubMed ID: 15665823 [TBL] [Abstract][Full Text] [Related]
4. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370 [TBL] [Abstract][Full Text] [Related]
6. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654 [TBL] [Abstract][Full Text] [Related]
7. Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-β and RANTES production. Siednienko J; Gajanayake T; Fitzgerald KA; Moynagh P; Miggin SM J Immunol; 2011 Feb; 186(4):2514-22. PubMed ID: 21248248 [TBL] [Abstract][Full Text] [Related]
8. Negative regulation of Toll-like-receptor signaling by IRF-4. Negishi H; Ohba Y; Yanai H; Takaoka A; Honma K; Yui K; Matsuyama T; Taniguchi T; Honda K Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15989-94. PubMed ID: 16236719 [TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139 [TBL] [Abstract][Full Text] [Related]
10. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Schmitz F; Heit A; Guggemoos S; Krug A; Mages J; Schiemann M; Adler H; Drexler I; Haas T; Lang R; Wagner H Eur J Immunol; 2007 Feb; 37(2):315-27. PubMed ID: 17273999 [TBL] [Abstract][Full Text] [Related]
11. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages. Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728 [TBL] [Abstract][Full Text] [Related]
12. Induction of iNOS by Chlamydophila pneumoniae requires MyD88-dependent activation of JNK. Rodriguez N; Lang R; Wantia N; Cirl C; Ertl T; Dürr S; Wagner H; Miethke T J Leukoc Biol; 2008 Dec; 84(6):1585-93. PubMed ID: 18799752 [TBL] [Abstract][Full Text] [Related]
13. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Honda K; Yanai H; Mizutani T; Negishi H; Shimada N; Suzuki N; Ohba Y; Takaoka A; Yeh WC; Taniguchi T Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15416-21. PubMed ID: 15492225 [TBL] [Abstract][Full Text] [Related]
14. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. Reiling N; Ehlers S; Hölscher C Immunol Lett; 2008 Feb; 116(1):15-23. PubMed ID: 18191460 [TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Kawai T; Sato S; Ishii KJ; Coban C; Hemmi H; Yamamoto M; Terai K; Matsuda M; Inoue J; Uematsu S; Takeuchi O; Akira S Nat Immunol; 2004 Oct; 5(10):1061-8. PubMed ID: 15361868 [TBL] [Abstract][Full Text] [Related]
16. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists. Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456 [TBL] [Abstract][Full Text] [Related]
17. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists. Youn HS; Lim HJ; Choi YJ; Lee JY; Lee MY; Ryu JH Int Immunopharmacol; 2008 Mar; 8(3):495-501. PubMed ID: 18279804 [TBL] [Abstract][Full Text] [Related]
19. Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury. Velayudham A; Hritz I; Dolganiuc A; Mandrekar P; Kurt-Jones E; Szabo G J Hepatol; 2006 Dec; 45(6):813-24. PubMed ID: 16935388 [TBL] [Abstract][Full Text] [Related]
20. Pathological role of Toll-like receptor signaling in cerebral malaria. Coban C; Ishii KJ; Uematsu S; Arisue N; Sato S; Yamamoto M; Kawai T; Takeuchi O; Hisaeda H; Horii T; Akira S Int Immunol; 2007 Jan; 19(1):67-79. PubMed ID: 17135446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]